Congenital hypothyroidism in Bogotá, Colombia: a current description (2015–2021)
-
Pablo Pineda-Sanabria
,
Esteban Portilla-Rojas
,
María Camila León-Sanabria
,
Daniela-Sofía Beltrán-Barriga
,
Alexander Salazar-Reviakina
,
Ana María Urueña Serrano
,
Karen Sarmiento
and
Ignacio Zarante
Abstract
Objectives
Congenital hypothyroidism (CH) is a decrease in thyroid hormone function in newborns, being one of the leading causes of neurological deficits and long-term metabolic complications. This study aims to determine the prevalence and characteristics of CH cases in Bogotá, Colombia, between 2015 and 2021, as notified through the mandatory report to the Public Health Surveillance System (PHSS).
Methods
A retrospective cross-sectional study was conducted. All live births (LB) with a weight ≥500 g, diagnosed with CH with or without goiter (ICD-10 codes E030 and E031, respectively) in Bogotá during 2015–2021 were analyzed.
Results
For a total of 201 cases, the prevalence rate was 3.29 cases per 10,000 LB. 92.54 % were classified as isolated cases of CH, 4.48 % syndromic, and 2.98 % polymalformated. A total of 16.92 % was small for gestational age. The mean gestational age was 37.38 weeks (SD 2.76), 26.87 % were preterm births. Among the mothers, 8.96 % suffered from pregnancy-related or chronic diseases, the most common being hypertensive disorders of pregnancy and pre-existant hypothyroidism (without clarity concerning etiology). A total of 66.67 % of cases did not receive treatment after diagnosis. Treatment was established by an average age of 27 days after birth (SD 36.02) and 17 days after case notification to the PHSS (SD 36.13).
Conclusions
Observed prevalence is similar to the rate reported by health authorities in Colombia but inferior to reports from high-income countries, highlighting the importance of improvements in the Colombian LB’s screening program. Time to diagnosis and treatment was observed to be prolonged, suggesting that new pathways are required for timely CH treatment.
Acknowledgments
To the Secretary of Health of Bogotá and the Program for Prevention and Surveillance of Birth Defects and Rare Diseases (PREVERDEC).
-
Research funding: None declared.
-
Author contributions: The study conception, design, material preparation, data collection, analysis, and manuscript elaboration were performed by PP, SB, AS, EP, MCLS, KS, and IZ. AMU performed verification of the data provided. IZ performed a critical analysis of the content. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Competing interests: The authors have no conflicts of interest to declare.
-
Informed consent: Informed consent was not necessary due to the nature of the data included in the study.
-
Ethical approval: Ethical approval was waived by the local Ethic Committee of Pontificia Universidad Javeriana, given the study's retrospective nature and that all the procedures being performed were part of routine care. Approval code: FM-CIE-8324-14.
References
1. Hinton, CF, Harris, KB, Borgfeld, L, Drummond-Borg, M, Eaton, R, Lorey, F, et al.. Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics 2010;125(2 Suppl):S37–47. https://doi.org/10.1542/peds.2009-1975d.Search in Google Scholar PubMed
2. Ford, G, LaFranchi, SH. Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pract Res Clin Endocrinol Metabol 2014;28:175–87. https://doi.org/10.1016/j.beem.2013.05.008.Search in Google Scholar PubMed
3. Ospina Martínez, ML, Prieto Alvarado, FE. Congenital defects report. Bogotá, Colombia: Colombian National Institute of Health; 2021:21 p.Search in Google Scholar
4. Ojeda Rincon, SA, Gualdron Rincon, EF, Garcia Rueda, NA, Sarmiento Villamizar, DF, Parada Botello, NS, Gelves Diaz, SA, et al.. Congenital hypothyroidism, the first cause of preventable mental retardation: a challenge for preventive medicine. Rev Médicas UIS. 2016;29:53–60. https://doi.org/10.18273/revmed.v29n1-2016006.Search in Google Scholar
5. Chan, SY, Vasilopoulou, E, Kilby, MD. The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metabol 2009;5:45–54. https://doi.org/10.1038/ncpendmet1026.Search in Google Scholar PubMed
6. Rastogi, MV, LaFranchi, SH. Congenital hypothyroidism. Orphanet J Rare Dis 2010;5:17. https://doi.org/10.1186/1750-1172-5-17.Search in Google Scholar PubMed PubMed Central
7. Colombian National Institute of Health. Congenital defects surveillance protocol. Non-communicable diseases surveillance and control group. [Internet]; 2023. Jan [cited 2023 Jun 11]. Available from: https://www.ins.gov.co/buscador-eventos/SitePages/Evento.aspx?Event=18].Search in Google Scholar
8. LaFranchi, SH, Rastogi, MV. Orphanet: congenital hypothyroidism [Internet]; 2010. [cited 2022 Nov 7]. Available from: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=442.Search in Google Scholar
9. Hinojosa Trejo, MA, Vela Amieva, M, Ibarra González, I, De Cosío Farias, AP, del Herrera Pérez, LA, Caamal Parra, G, et al.. Birth prevalence of congenital hypothyroidism. Acta Pediátrica México 2018;39:5. https://doi.org/10.18233/apm39no6pp5s-13s1717.Search in Google Scholar
10. van Trotsenburg, P, Stoupa, A, Léger, J, Rohrer, T, Peters, C, Fugazzola, L, et al.. Congenital hypothyroidism: a 2020–2021 consensus guidelines update—an ENDO-European reference network initiative endorsed by the European society for pediatric endocrinology and the European society for endocrinology. Thyroid 2021;31:387–419. https://doi.org/10.1089/thy.2020.0333.Search in Google Scholar PubMed PubMed Central
11. Albert, BB, Cutfield, WS, Webster, D, Carll, J, Derraik, JGB, Jefferies, C, et al.. Etiology of increasing incidence of congenital hypothyroidism in New Zealand from 1993–2010. J Clin Endocrinol Metab 2012;97:3155–60. https://doi.org/10.1210/jc.2012-1562.Search in Google Scholar PubMed
12. Peñaloza, L, Forero, C, Céspedes, C. Characterization of patients with congenital hypothyroidism in hospital universitario san Ignacio between 2001 and 2017. Biomedica 2020;40:528–33. https://doi.org/10.7705/biomedica.5334.Search in Google Scholar PubMed PubMed Central
13. Boileau, P, Bain, P, Rives, S, Toublanc, JE. Earlier onset of treatment or Increment in LT4 dose in screened congenital hypothyroidism: which was the more important factor for IQ at 7 Years? Horm Res Paediatr 2004;61:228–33. https://doi.org/10.1159/000076597.Search in Google Scholar PubMed
14. Rahmani, K, Yarahmadi, S, Etemad, K, Koosha, A, Mehrabi, Y, Aghang, N, et al.. Congenital hypothyroidism: optimal initial dosage and time of initiation of treatment: a systematic review. Int J Endocrinol Metab 2016;14:e36080. https://doi.org/10.5812/ijem.36080.Search in Google Scholar PubMed PubMed Central
15. Multicenter Study Collaborative Group for Evaluation of Outcomes in Very Low Birth Weight Infants. [Perinatal risk factors for congenital hypothyroidism in very preterm infants: a multicenter prospective study]. Zhonghua Er Ke Za Zhi Chin J Pediatr 2022;60:545–50.Search in Google Scholar
16. Sardana, G, Malwade, S, Agarkhedkar, S. Prevalence and risk factors associated with elevated thyroid stimulating hormone in late preterm newborns with low birthweight: a cross-sectional study. J Neonatol 2022;36:173–6. https://doi.org/10.1177/09732179221100504.Search in Google Scholar
17. Herrera-Chinchay, L, Silva-Ocas, I, Castro-Silva, N, Del Águila Villar, C. Social, cognitive and psicomotor development in peruvian children with congenital hypothyroidism. Andes Pediatr 2021;92:235. https://doi.org/10.32641/andespediatr.v92i2.1955.Search in Google Scholar PubMed
18. Huo, K, Zhang, Z, Zhao, D, Li, H, Wang, J, Wang, X, et al.. Risk factors for neurodevelopmental deficits in congenital hypothyroidism after early substitution treatment. Endocr J 2011;58:355–61. https://doi.org/10.1507/endocrj.k10e-384.Search in Google Scholar PubMed
19. Bran Piedrahita, L, Valencia Arias, A, Palacios Moya, L, Gómez Molina, S, Acevedo Correa, Y, Arias Arciniegas, C, et al.. Access barriers to healthcare system in Colombian rural areas: subsidiary regime user perceptions. Hacia Promoc Salud 2020;25:29–38. https://doi.org/10.17151/hpsal.2020.25.2.6.Search in Google Scholar
© 2023 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Original Articles
- Metabolic risk factors in prepubertal and pubertal patients with overweight and obesity
- Blood pressure in girls with central precocious puberty receiving GnRH analogue therapy
- Norethindrone dosing for adequate menstrual suppression in adolescents
- Apparent diffusion coefficient (ADC) measurements and morphometric evaluation of the cranium in age-matched children with central precocious puberty
- Characteristics of vitamin D deficiency hypocalcemia inpatient admissions at a single tertiary center
- Early pregnancy exposure of maternal triglyceride levels and its effects on birth weight
- Evaluation of the clinical, biochemical, and genetic presentation of neonatal and adult-onset 5,10-methylene tetrahydrofolate reductase (MTHFR) deficiency in patients from Pakistan
- Congenital hypothyroidism in Bogotá, Colombia: a current description (2015–2021)
- Case Reports
- Case report: mitochondrial diabetes mellitus in a Chinese family due to m.3243A>G
- Novel pathogenic variant of DICER1 in an adolescent with multinodular goiter, ovarian Sertoli–Leydig cell tumor and pineal parenchymal tumor of intermediate differentiation
- Fibroblast growth factor 23 levels in cord and peripheral blood during early neonatal period as possible predictors of affected offspring of X-linked hypophosphatemic rickets: report of three female cases from two pedigrees
- A rare cause of hyperphenylalaninemia: four cases from a single family with DNAJC12 deficiency
- The benefit of rhGH therapy in a Chinese child with 12q14 microdeletion syndrome: a case report
- Adjustment of octreotide dose given via insulin pump based on continuous glucose monitoring (CGM) in a child with congenital hyperinsulinism
Articles in the same Issue
- Frontmatter
- Original Articles
- Metabolic risk factors in prepubertal and pubertal patients with overweight and obesity
- Blood pressure in girls with central precocious puberty receiving GnRH analogue therapy
- Norethindrone dosing for adequate menstrual suppression in adolescents
- Apparent diffusion coefficient (ADC) measurements and morphometric evaluation of the cranium in age-matched children with central precocious puberty
- Characteristics of vitamin D deficiency hypocalcemia inpatient admissions at a single tertiary center
- Early pregnancy exposure of maternal triglyceride levels and its effects on birth weight
- Evaluation of the clinical, biochemical, and genetic presentation of neonatal and adult-onset 5,10-methylene tetrahydrofolate reductase (MTHFR) deficiency in patients from Pakistan
- Congenital hypothyroidism in Bogotá, Colombia: a current description (2015–2021)
- Case Reports
- Case report: mitochondrial diabetes mellitus in a Chinese family due to m.3243A>G
- Novel pathogenic variant of DICER1 in an adolescent with multinodular goiter, ovarian Sertoli–Leydig cell tumor and pineal parenchymal tumor of intermediate differentiation
- Fibroblast growth factor 23 levels in cord and peripheral blood during early neonatal period as possible predictors of affected offspring of X-linked hypophosphatemic rickets: report of three female cases from two pedigrees
- A rare cause of hyperphenylalaninemia: four cases from a single family with DNAJC12 deficiency
- The benefit of rhGH therapy in a Chinese child with 12q14 microdeletion syndrome: a case report
- Adjustment of octreotide dose given via insulin pump based on continuous glucose monitoring (CGM) in a child with congenital hyperinsulinism
